- Overview Press tab for submenu items
TCS is here to make a difference through technology.
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
-
Industries
-
Services
-
Products and Platforms
- Overview Press tab for submenu items
We deliver excellence and create value for customers and communities.
Our expert, committed team put our shared values into action – every day. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
-
About Us
-
Research & Innovation
-
Our Brand
- Overview Press tab for submenu items
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Customer Stories
-
Perspectives
-
Global studies
-
Topics
- Overview Press tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Overview
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
- Overview Press tab for submenu items
Find the latest news about TCS in our Newsroom
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
-
Press releases
-
News alerts
-
Analyst recognition
Recent recognitions
View all -
Events
-
Media kit
- Overview Press tab for submenu items
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Overview
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
Top Results
Showing
10
01 - 07
Next-gen clinical trials via digital platform
Matthew Moyer, Director - Operations and supply tech, Merck, and Narayanan R., Chief Architect - TCS ADD™, discuss and demonstrate approaches and real-life examples to enable patient-centric trials through a unified, integrated platform.
14 MINS WATCH
You have these already downloaded
We have sent you a copy of the report to your email again.
Products and Platforms
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
This paper dives into how AI technology is unifying fragmented clinical data to make clinical trials more patient-centric, effective, safer, and efficient.
Article
20 May 2025
Hosted by TCS ADD™, the invite-only event will see leaders talk about the role of AI/Generative AI in life sciences. Register for the leadership forum now.
Events
14 Feb 2025
Join us at the life sciences event to learn how AI and generative AI can accelerate next-gen clinical R&D and enhance patient safety. Register now for the event.
Events
07 Aug 2024
Highlights
- Merck partnered with TCS to realize its vision of a digitally enabled trials platform (DETP), leveraging TCS ADD’s decentralized trials solution.
- Merck and TCS jointly tested a host of features such as electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer, and bring-your-own-device (BYOD).
- The digitally enabled trials platform (DETP) aims to resolve challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy, and calculating RoI.
Enabling patient-centric trials
Clinical trials have been primarily driven by a site-centric approach (such as face-to-face interactions at the site).
The COVID-19 pandemic severely impacted the functioning of traditional clinical trials and opened a world of possibilities to move to the next generation of clinical trials. Augmented by digital technologies, clinical trials improve participant access, engagement enabling patient-centricity.
Merck partnered with TCS to realize its vision of a digitally enabled trials platform (DETP), leveraging TCS ADD’s decentralized trials solution. The DETP was aimed at resolving challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy, and calculating RoI.
The partnership facilitated a host of features being actively tested, viz-a-viz, electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer, and BYOD.
Related reading
1/4
TCS ADD™
Artificial Intelligence – A Game Changer in Unifying Clinical Data
Article
|
20 May 2025
Opens in new tab
2/4
TCS ADD™ Webinar: Shaping the Future of AI-driven SDTM Harmonization
video
|
22 Apr 2025
Opens in new tab
3/4
TCS ADD™
Vandita Tripathi
Manas Saha
Automating Third Party Data Transfer Through Digitized Electronic DTA
White Paper
|
18 Dec 2024
Opens in new tab
4/4
Solutions
TCS ADD™ Risk-Based Quality Management Platform
Solution
|
25 Sep 2024
Opens in new tab
Transformation starts here
Integrated ecosystems are key to better patient outcomes.
Talk to our expertsFind out more
©2025 TATA Consultancy Services Limited
©2025 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Accessibility Declaration
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?